B-cell Non-Hodgkin's Lymphoma
B-cell Non-Hodgkin's Lymphoma is a type of cancer that originates in the B-cells, which are part of the immune system. It can be aggressive and may return after treatment, leading to relapsed or refractory cases.
B-cell Non-Hodgkin Lymphoma: Loncastuximab Tesirine Study
We are testing a new treatment combining Loncastuximab Tesirine with other anti-cancer agents for patients with relapsed or refractory B-cell Non-Hodgkin Lymphoma. The goal is to evaluate its safety and potential effectiveness.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitair Ziekenhuis Gent
Hematology
Ledeberg, Belgium
Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur
Hematology
Profondeville, Belgium
Fakultni Nemocnice Brno
Interní hematologická a onkologická klinika
Brno, Czechia
Sponsor: ADC Therapeutics SA
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.